ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

Monroe Wall, Co-Discoverer Of Taxol, Camptothecin, Dead At 85

July 12, 2002

Elderly Men Say Physicians Are Recommending PSA Tests

December 26, 2003

NCAB Subcommittee Tells Califano To Keep Hands Off Board Appointments

May 18, 1979

Wynder’s Low Fat Adjuvant Breast Cancer Study Finally Funded

October 21, 1988

James Abbruzzese Moves to Duke Cancer Institute

September 27, 2013

Panel to Hear Innovation Reports

August 26, 1988